History of Fine Chemical Business
- *The Pharmaceuticals & Fine Chemicals Business inherited the chemical business operations of our former company Daiichi Pure Chemicals.
|1947||Daiichi Pure Chemicals Co., Ltd. established on July 10th.
The Yanagishima Plant started to manufacture hydrosulfite, lactic acid, and ethyl lactate.
|1948||Started to manufacture sulfosalicylic acid, an in vitro diagnostic.|
|1953||Started to manufacture ZONON®, a metal chelator.|
|1954||Started to manufacture para-aminosalicylic acid, an API.|
|1958||Started to manufacture and market amino acids. Acquired patent related to the manufacturing of amino acids.|
|1960||Construction of the Funabori Factory completed.|
|1969||Started to manufacture L-DOPA.|
|1973||Acquired land in Hachimantai (then known as Matsuo-mura), Iwate Prefecture.|
|1977||Agreement on environmental pollution control concluded with Hachimantai (Matsuo-mura), Iwate Prefecture.|
|1978||Construction of Iwate Plant (Stage 1) completed. Acquired Dowa Kasei Kogyo.|
|1979||Iwate Plant inaugurated.|
|1981||Construction of Iwate Plant (Stage 2) completed.|
|1984||Underwent first FDA inspection.|
|1985||Funabori Plant closed and production transferred to the Iwate Plant.
Construction of Iwate Plant (Stage 3) completed.
|1992||Construction of the Iwate Plant and anaerobic wastewater treatment facility completed.|
|1994||Daiichi Pure Chemical Quality Assurance Charter enacted.|
|2000||Construction of Iwate Plant (Stage 4) completed.|
|2001||Iwate Plant acquired IS014001 certification.|
|2004||Iwate Plant IS014001 certification renewed.|
|2006||Construction of Iwate Plant (Stage 5) completed.|
|2007||Iwate Plant IS014001 certification renewed.|
|2008||Merger of Daiichi Pure Chemical chemical business and Sekisui Chemical medical business. Came into operation as the Sekisui Medical Co. Ltd. Pharmaceuticals & Fine Chemicals Business
Underwent EDQM inspection.
|2011||Expanded contract manufacturing of peptide pharmaceuticals.
Underwent our 9th FDA inspection (in October).
|2012||Gave presentations about our peptide manufacturing technologies at events such as TIDES.|
|2013||Added a cleanroom for investigational new drugs and peptides.|
|2014||Installed preparative HPLC equipment and a freeze dryer in the cleanroom.|
|2016||Underwent 10th FDA inspection (in June).|
|2017||Underwent 11th FDA inspection (in July).
Added a clean room for medium volume GMP-compliant manufacturing (in September)
|2018||Added a building for API manufacturing.|